Hanall Biopharma, 3Q Operating Profit 2 Billion KRW... 109% Increase

[Asia Economy Reporter Ji Yeon-jin] HanAll Biopharma announced on the 27th that its sales in the third quarter of this year reached 25.4 billion KRW, an increase of 15.2% compared to the same period last year.

Operating profit during this period was 2 billion KRW, up 109.7%, while net profit decreased by 48.3% to 1.8 billion KRW.